Joseph Doyle

6.7k total citations · 2 hit papers
177 papers, 4.0k citations indexed

About

Joseph Doyle is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Joseph Doyle has authored 177 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Epidemiology, 122 papers in Hepatology and 33 papers in Infectious Diseases. Recurrent topics in Joseph Doyle's work include Hepatitis C virus research (119 papers), Hepatitis B Virus Studies (76 papers) and Liver Disease Diagnosis and Treatment (68 papers). Joseph Doyle is often cited by papers focused on Hepatitis C virus research (119 papers), Hepatitis B Virus Studies (76 papers) and Liver Disease Diagnosis and Treatment (68 papers). Joseph Doyle collaborates with scholars based in Australia, United States and United Kingdom. Joseph Doyle's co-authors include Margaret Hellard, James M. Trauer, Shantha M. W. Rajaratnam, David Cunnington, Alexander Thompson, Mark Stoové, Esther Aspinall, Alisa Pedrana, Sharon Hutchinson and David Goldberg and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Joseph Doyle

166 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cognitive Behavioral Therapy for Chronic Insomnia

2015 722 citations Joseph Doyle et al. profile →
Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis

2018 313 citations Michael W. Traeger, Margaret Hellard et al. profile →

Peers

Countries citing papers authored by Joseph Doyle

Since Specialization

Citations

This map shows the geographic impact of Joseph Doyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Doyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Doyle more than expected).

Fields of papers citing papers by Joseph Doyle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Doyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Doyle. The network helps show where Joseph Doyle may publish in the future.

Co-authorship network of co-authors of Joseph Doyle

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Doyle. A scholar is included among the top collaborators of Joseph Doyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Doyle. Joseph Doyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improving Hepatocellular Carcinoma Surveillance Outcomes in Patients with Cirrhosis after Hepatitis C Cure: A Modelling Study 2024 ·Cancers ·(unknown), Nick Scott, Jessica Howell, (unknown), (unknown), Margaret Hellard, (unknown), Marno Ryan, Tom Sutherland, Alexander Thompson, Joseph Doyle, Rachel Sacks‐Davis	1
2	Missed Opportunities: A Retrospective Study of Hepatitis C Testing in Hospital Inpatients 2024 ·Viruses ·Christine Röder, (unknown), Kathryn Mackie, Bridgette McNamara, Joseph Doyle, Amanda Wade	0
3	Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020 2024 ·Liver International ·(unknown), Rachel Sacks‐Davis, Daniela K van Santen, Michael W. Traeger, Anna L. Wilkinson, Jason Asselin, Christopher K. Fairley, Norman Roth, Mark Bloch, Gail Matthews, Basil Donovan, Rebecca Guy, Mark Stoové, Margaret Hellard, Joseph Doyle	2
4	The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia 2023 ·BMJ Open ·(unknown), Daniel O’Keefe, Bridget Draper, (unknown), Kathleen E. Ryan, (unknown), Imogen Elsum, Judy Gold, (unknown), (unknown), Paul Dietze, Peter Higgs, Joseph Doyle, Mark Stoové, Margaret Hellard, Alisa Pedrana	2
5	Leave No-One Behind: A Retrospective Study of Hepatitis C Testing and Linkage to Care for Hospital Inpatients 2023 ·Viruses ·Christine Röder, (unknown), Kathryn Mackie, Stuart K. Roberts, Margaret Hellard, Amanda Wade, Joseph Doyle	3
6	The impacts of COVID‐19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia 2023 ·Addiction ·(unknown), Paul A. Agius, Bernadette Ward, Matthew Hickman, Lisa Maher, Mark Stoové, Joseph Doyle, Margaret Hellard, Anna L. Wilkinson, Brendan Quinn, Sione Crawford, Keith Sutton, Paul Dietze	6
7	Determining reinfection rates by hepatitis C testing interval among key populations: A systematic review and meta‐analysis 2023 ·Liver International ·(unknown), Michael W. Traeger, (unknown), (unknown), Lakshmi Manoharan, Niklas Luhmann, Rachel Baggaley, Virginia Macdonald, Annette Verster, Nandi Siegfried, Brian Conway, Marina B. Klein, Julie Bruneau, Mark Stoové, Margaret Hellard, Joseph Doyle	2
8	Immediate treatment for recent hepatitis C infection in people with high-risk behaviors: a systematic review and meta-analysis 2023 ·Hepatology Communications ·Lakshmi Manoharan, (unknown), (unknown), Michael W. Traeger, (unknown), Niklas Luhmann, Rachel Baggaley, Virginia Macdonald, Annette Verster, Nandi Siegfried, Gail Matthews, Mark Stoové, Margaret Hellard, Joseph Doyle	2
9	Epidemiology of acute infections in people who inject drugs in Australia 2023 ·Drug and Alcohol Review ·(unknown), Daniel O’Keefe, Peter Higgs, Olga Vujovic, Joseph Doyle, Andrew J. Stewardson	3
10	Understanding how to live with hepatitis B: a qualitative investigation of peer advice for Chinese people living with hepatitis B in Australia 2022 ·BMC Public Health ·Jack Wallace, Yinzong Xiao, Jess Howell, A. Thompson, Nicole Allard, (unknown), Jacqui Richmond, Behzad Hajarizadeh, (unknown), Joseph Doyle, Margaret Hellard	3
11	The impact of point‐of‐care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian pilot study 2022 ·Journal of Viral Hepatitis ·Jessica Howell, Michael W. Traeger, Bridget Williams, (unknown), Joseph Doyle, (unknown), Bridget Draper, (unknown), (unknown), Maggie McPherson, Janine Roney, Mark Stoové, Alexander Thompson, Margaret Hellard, Alisa Pedrana	14
12	Impact of COVID‐19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs 2022 ·Journal of Viral Hepatitis ·Michael W. Traeger, Daniela K van Santen, Rachel Sacks‐Davis, Jason Asselin, Allison Carter, Joseph Doyle, Alisa Pedrana, Anna L. Wilkinson, Jessica Howell, (unknown), (unknown), Basil Donovan, Rebecca Guy, Margaret Hellard, Mark Stoové	6
13	Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol 2022 ·BMJ Open ·Tafireyi Marukutira, (unknown), Margaret Hellard, Jacqui Richmond, Kate Turner, Alisa Pedrana, Shannon Melody, Fay H. Johnston, Louise Owen, Wijnand van den Boom, Nick Scott, Alexander Thompson, David Iser, Tim Spelman, Mark Veitch, Mark Stoové, Joseph Doyle	1
14	High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an Australian Real‐World Cohort: The REACH‐C Study 2021 ·Hepatology Communications ·Jasmine Yee, (unknown), Behzad Hajarizadeh, (unknown), James O’Beirne, David Iser, Phillip Read, (unknown), Joseph Doyle, Jane Davies, Marianne Martinello, (unknown), Gregory J. Dore, Gail Matthews, (unknown)	12
15	The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health services 2020 ·PLoS ONE ·Michael W. Traeger, Alisa Pedrana, Daniela K van Santen, Joseph Doyle, Jessica Howell, Alexander Thompson, Carol El‐Hayek, Jason Asselin, (unknown), (unknown), (unknown), Allison Carter, Rebecca Guy, Mark Stoové, Margaret Hellard	9
16	Eliminating hepatitis C by 2030: Hospital presentation provides opportunities for engagement and treatment of marginalized individuals with chronic hepatitis C 2019 ·Journal of Gastroenterology and Hepatology ·(unknown), Karen New, Sean C. Glasgow, (unknown), Catherine Croagh, Patricia Desmond, (unknown), (unknown), Hong Tang, Jessica Howell, Marno Ryan, Joseph Doyle, A. Thompson	1
17	A survey of hepatitis C management by Victorian GPs after PBS-listing of direct-acting antiviral therapy. 2017 ·PubMed ·Amanda Wade, Bridget Draper, Joseph Doyle, Nicole Allard, (unknown), Alexander Thompson, Margaret Hellard	18
18	Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model 2016 ·Gut ·Nick Scott, Emma S. McBryde, Alexander Thompson, Joseph Doyle, Margaret Hellard	115
19	Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis 2013 ·International Journal of Epidemiology ·Esther Aspinall, Dhanya Nambiar, David Goldberg, Matthew Hickman, Amanda Weir, (unknown), Norah Palmateer, Joseph Doyle, Margaret Hellard, Sharon Hutchinson	259
20	Oseltamivir Resistance in Adult Oncology and Hematology Patients Infected with Pandemic (H1N1) 2009 Virus, Australia 2010 ·Emerging infectious diseases ·Adrian R Tramontana, Biju George, Aeron C. Hurt, Joseph Doyle, (unknown), Alistair Reid, (unknown), Karin Thursky, Leon J. Worth, Dominic E. Dwyer, C. Orla Morrissey, Paul D.R. Johnson, Kirsty Buising, Simon J. Harrison, John F. Seymour, Patricia E. Ferguson, (unknown), Justin T. Denholm, Allen Cheng, Monica A. Slavin	92

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact